Skip to main content
×
Home
    • Aa
    • Aa

Current Strategies for Managing Providers Infected with Bloodborne Pathogens

  • Sarah Turkel (a1) and David K. Henderson (a1) (a2)
Abstract
Background.

In 1991 the Centers for Disease Control and Prevention issued guidelines to reduce risks for provider-to-patient transmission of bloodborne pathogens. These guidelines, unchanged since 1991, recommend management strategies for hepatitis B e antigen-positive providers and for providers infected with human immunodeficiency virus; they do not address hepatitis C virus (HCV)-infected providers.

Objective.

We summarized current state practices and surveyed state health departments to determine (1) whether state policies have been modified since 1991; (2) whether state laws require prospective notification of patients and/or expert review panels to manage infected providers; (3) the frequency with which infected-providers issues come to the attention of state health departments; and (4) how state health departments intervene.

Methods.

We reviewed the 50 states' laws and guidelines to determine current practices and conducted a structured telephone survey of all state health departments.

Results.

Whereas only 19 states require infected providers to notify patients of the providers’ bloodborne pathogen infection, these 19 states require notification under highly varied circumstances. Only 10 of 50 state health department officials identified these issues as requiring significant departmental effort. No state law or guideline incorporates information about providers’ viral burdens as part of the risk assessment. Only 3 of 50 states have modified policies or laws since initial passage, and only 1 of 50 discusses the management of HCV-infected providers.

Conclusions.

These results identify a need for incorporating contemporary scientific information into guidelines and also suggest that infected-provider issues are not occurring commonly, are not being detected, or are being managed at levels below the state health department.

Copyright
Corresponding author
Building 10, Room 6-1480, 10 Center Drive, Bethesda, MD 20892 (dkh@nih.gov)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. HJ Alter . Hepatitis B and the health worker: prospective studies in perspective. Ann Intern Med 1976;85:971972.

3. D Bell , CN Shapiro , CA Ciesielski , ME Chamberland . Preventing bloodborne pathogen transmission from health-care workers to patients: the CDC perspective. Surg Clin North Am 1995;75:11891203.

4. R Harpaz , L Von Seidlein , FM Averhoff , et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996;334:549554.

6.Incident Investigation Teams and others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 1997;336:178184.

8. IF Laurenson , DG Jones , NF Hallam , CJ Saunders , DM Fraser , WF Carman . Transmission of hepatitis B virus from a vaccinated healthcare worker. J Hosp Infect 2007;66:393394.

9. P Brown . Surgeon infects patient with hepatitis C. Br Med J (Clin Res Ed) 1999;319:1219.

10. SH Cody , OV Nainan , RS Garfein , et al. Hepatitis C vims transmission from an anesthesiologist to a patient. Arch Intern Med 2002;162:345350.

12. JI Esteban , J Gomez , M Martell , et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555560.

13. J Mawdsley , CG Teo , M Kyi , M Anderson . Anesthetist to patient transmission of hepatitis C virus associated with non exposure-prone procedures. J Med Virol 2005;75:399401.

19. RS Ross , S Viazov , M Roggendorf . Phylogenetic analysis indicates transmission of hepatitis C virus from an infected orthopedic surgeon to a patient. J Med Virol 2002;66:461467.

20. Y Shemer-Avni , M Cohen , A Keren-Naus , et al. Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions. Clin Infect Dis 2007;45:e32e38.

21. IT Williams , JF Perz , BP Bell . Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 2004;38:15921598.

25. C Ciesielski , D Marianos , C-Y Ou , et al. Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med 1992;116:798805.

26. CA Ciesielski , DM Bell , DW Marianos . Transmission of HIV from infected health-care workers to patients. AIDS 1991;5(suppl 2):S93S97.

27. CY Ou , CA Ciesielski , G Myers , et al. Molecular epidemiology of HIV transmission in a dental practice. Science 1992;256:1165—1171.

29. SH Weiss . Risks and issues for the health care worker in the human immunodeficiency virus era. Med Clin North Am 1997;81:555575.

32. DK Henderson . Human immunodeficiency virus in the healthcare Setting. In: GL Mandell , JE Bennett , R Dolin , eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier, 2010:37533770.

35. JL Dienstag , JG McHutchison . American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006;130:231264.

39. E Jaeckel , M Cornberg , H Wedemeyer , et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:14521457.

40. J Wiegand , K Deterding , M Cornberg , H Wedemeyer . Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha. J Antimicrob Chemother 2008;62:860865.

41. P Fabris . Acute hepatitis C: epidemiology, pathogenesis and therapy. Curr Pharm Des 2008;14(17):16441645.

43. EH Buster , AA van der Eijk , SW Schalm . Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions. Antiviral Res 2003;60:7985.

49. D FitzSimons , G Francois , G De Carli , et al. Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries. Occup Environ Med 2008;65:446451.

50. RN Gunson , D Shouval , M Roggendorf , et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003;27:213230.

52. AM Reitsma , ML Closen , M Cunningham , et al. Infected physicians and invasive procedures: safe practice management. Clin Infect Dis 2005;40:16651672.

53. AA van der Eijk , RA de Man , HG Niesters , SW Schalm , HL Zaaijer . Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers. J Viral Hepat 2006;13:24.

54. J Tuboku-Metzger , L Chiarello , RL Sinkowitz-Cochran , A Casano-Dickerson , D Cardo . Public attitudes and opinions toward physicians and dentists infected with bloodborne viruses: results of a national survey. Am J Infect Control 2005;33:299303.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×